Uses of polypills for cardiovascular disease and evidence to date

This publication has 51 references indexed in Scilit:

• Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD
  JAMA, 2013
• Trends in Vascular Risk Factor Treatment and Control in US Stroke Survivors
  Circulation: Cardiovascular Quality and Outcomes, 2013
• The Evening versus Morning Polypill Utilization Study: the TEMPUS rationale and design
  European Journal of Preventive Cardiology, 2013
• Randomized Polypill Crossover Trial in People Aged 50 and Over
  PLOS ONE, 2012
• Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases
  Circulation: Cardiovascular Quality and Outcomes, 2012
• An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk
  PLOS ONE, 2011
• A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
  Trials, 2011
• Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial
  Vascular Health and Risk Management, 2010
• The polypill story from a ringside seat
  Journal of the Royal Society of Medicine, 2009
• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
  BMJ, 2008